

| 1937 | Foundation of Laboratorios Vita, S.A. | |||
| 1961 | Vita directs its activity to the prescription pharmaceutical market. | |||
| 1979 | Purchase of Laboratorios Lesvi, S.A. | |||
| 1980 | Foundation of the chemical plant INKE, S.A. | |||
| 1995 | Joint-venture with BAYER | |||
| 1998 | Beginning of international expansion | |||
| 2002 | Ending of BAYER joint-venture | |||
| 2004 | Purchase of Vita by Procter&Gamble | |||
| 2005 | Purchase of Laboratorios LESVI, S.L. and the chemical plant INKE, S.A. by Invent Farma (Iceland) | |||
| 2006 | Foundation of Qualigen, S.L. | |||
| 2006 | Foundation of Laboratorios DOMAC, S.L. (Joint Venture between Invent Farma, S.L. and Strides Arcolab, LTD) | |||
| 2007 | Purchase of 75% of Lyfjaver | |||
| 2007 | Purchase of 50% of Farmaplus |
Since its present our vertically integrated company group (LESVI-INKE) has undergone a steadly growth to become today among Spain’s top Pharmaceutical companies.
LESVI-INKE uses mainly its own environmentally respectful technology for all of its integrated activities, from the manufacture of active ingredients, to in-house R&D and the production and sale of ethical pharmaceutical products.
Our highly skilled, dedicated and motivated 300 employees team with their commitment to the service of the Health Care industry make our Mission come true.
It is the dedication and enthusiasm of our employees that makes LESVI-INKE group a solid undertaking today with a great future lying ahead.